Arrowhead Pharmaceuticals (ARWR) Non-Current Assets (2010 - 2026)
Arrowhead Pharmaceuticals' Non-Current Assets came in at $440.6 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 1.6% from $433.69 million a year earlier and up 2.8% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Non-Current Assets was $434.66 million, down 2.2% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 16.8% (FY2020 to FY2025).
- Going back by fiscal year, Non-Current Assets was $444.33 million in FY2024 (+27.3%), $349.08 million in FY2023 (+21.8%), $286.64 million in FY2022 (-12.0%) and $325.55 million in FY2021 (+62.7%).
- The fiscal Q3 2026 figure represents the highest quarterly Non-Current Assets since fiscal Q1 2025.
- Year-over-year, Non-Current Assets increased in four of the last eight quarters, with growth averaging 5.2%.
- The fastest year-over-year change in Non-Current Assets over five years came in fiscal Q1 2022 (growth of 71.1%), and the weakest in fiscal Q4 2022 (a decline of 12.0%).
- Business Quant data shows ARWR's Non-Current Assets at $428.51 million (Q2 2026), $429.79 million (Q1 2026) and $434.66 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 440.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 440.60 Mn |
| Mar 31, 2026 | 428.51 Mn |
| Dec 31, 2025 | 429.79 Mn |
| Sep 30, 2025 | 434.66 Mn |
| Jun 30, 2025 | 433.69 Mn |
| Mar 31, 2025 | 438.28 Mn |
| Dec 31, 2024 | 443.16 Mn |
| Sep 30, 2024 | 444.33 Mn |
| Jun 30, 2024 | 433.70 Mn |
| Mar 31, 2024 | 413.50 Mn |
| Dec 31, 2023 | 388.39 Mn |
| Sep 30, 2023 | 349.08 Mn |
| Jun 30, 2023 | 325.69 Mn |
| Mar 31, 2023 | 316.50 Mn |
| Dec 31, 2022 | 316.49 Mn |
| Sep 30, 2022 | 286.64 Mn |
| Jun 30, 2022 | 319.39 Mn |
| Mar 31, 2022 | 285.95 Mn |
| Dec 31, 2021 | 300.26 Mn |
| Sep 30, 2021 | 325.55 Mn |
API Access
Arrowhead Pharmaceuticals Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();